Related references
Note: Only part of the references are listed.Glucocorticoid Signaling Enhances Expression of Glucose-Sensing Molecules in Immature Pancreatic Beta-Like Cells Derived from Murine Embryonic Stem Cells In Vitro
Nadiah Ghazalli et al.
STEM CELLS AND DEVELOPMENT (2018)
Novel selective thiadiazine DYRK1A inhibitor lead scaffold with human pancreatic β-cell proliferation activity
Kunal Kumar et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
CC-401 Promotes β-Cell Replication via Pleiotropic Consequences of DYRK1A/B Inhibition
Yassan Abdolazimi et al.
ENDOCRINOLOGY (2018)
Glucocorticoids Reprogram beta-Cell Signaling to Preserve Insulin Secretion
Nicholas H. F. Fine et al.
DIABETES (2018)
Cell cycle proteins as promising targets in cancer therapy
Tobias Otto et al.
NATURE REVIEWS CANCER (2017)
Direct effect of glucocorticoids on glucose-activated adult rat β-cells increases their cell number and their functional mass for transplantation
Zerihun Assefa et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2016)
Inhibition of DYRK1A Stimulates Human β-Cell Proliferation
Ercument Dirice et al.
DIABETES (2016)
Tyrosine kinase inhibitors under investigation for the treatment of type II diabetes
Rana Malek et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2016)
Replicative capacity of β-cells and type 1 diabetes
Diane Saunders et al.
JOURNAL OF AUTOIMMUNITY (2016)
High-throughput Functional Genomics Identifies Regulators of Primary Human Beta Cell Proliferation
Karine Robitaille et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Advances in β cell replacement and regeneration strategies for treating diabetes
Jacqueline R. Benthuysen et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Imatinib prevents beta cell death in vitro but does not improve islet transplantation outcome
Aileen J. F. King et al.
UPSALA JOURNAL OF MEDICAL SCIENCES (2016)
Combined inhibition of the cell cycle related proteins Wee1 and Chk1/2 induces synergistic anti-cancer effect in melanoma
Gry Irene Magnussen et al.
BMC CANCER (2015)
Non-receptor tyrosine kinase inhibitors enhances β-cell survival by suppressing the PKCδ signal transduction pathway in streptozotocin - induced β-cell apoptosis
Udayakumar Karunakaran et al.
CELLULAR SIGNALLING (2015)
Early and Late G1/S Cyclins and Cdks Act Complementarily to Enhance Authentic Human β-Cell Proliferation and Expansion
Shiwani Tiwari et al.
DIABETES (2015)
Human β-Cell Proliferation and Intracellular Signaling: Part 3
Andrew F. Stewart et al.
DIABETES (2015)
A high-throughput chemical screen reveals that harmine-mediated inhibition of DYRK1A increases human pancreatic beta cell replication
Peng Wang et al.
NATURE MEDICINE (2015)
Combination immunotherapies for type 1 diabetes mellitus
Paolo Pozzilli et al.
NATURE REVIEWS ENDOCRINOLOGY (2015)
Inhibition of DYRK1A and GSK3B induces human β-cell proliferation
Weijun Shen et al.
NATURE COMMUNICATIONS (2015)
Chk1 inhibition in p53-deficient cell lines drives rapid chromosome fragmentation followed by caspase-independent cell death
Christopher J. Del Nagro et al.
CELL CYCLE (2014)
Dyrk1A induces pancreatic β cell mass expansion and improves glucose tolerance
Latif Rachdi et al.
CELL CYCLE (2014)
Type 2 Diabetes and Congenital Hyperinsulinism Cause DNA Double-Strand Breaks and p53 Activity in β Cells
Sharona Tornovsky-Babeay et al.
CELL METABOLISM (2014)
G0-G1 Transition and the Restriction Point in Pancreatic β-Cells In Vivo
Ayat Hija et al.
DIABETES (2014)
Repurposing cAMP-Modulating Medications to Promote β-Cell Replication
Zhenshan Zhao et al.
MOLECULAR ENDOCRINOLOGY (2014)
Glucose Regulates Rat Beta Cell Number through Age-Dependent Effects on Beta Cell Survival and Proliferation
Zerihun Assefa et al.
PLOS ONE (2014)
Whole Organism High Content Screening Identifies Stimulators of Pancreatic Beta-Cell Proliferation
Naoki Tsuji et al.
PLOS ONE (2014)
Human Pancreatic β-Cell G1/S Molecule Cell Cycle Atlas
Nathalie M. Fiaschi-Taesch et al.
DIABETES (2013)
Glucokinase Activation Ameliorates ER Stress-Induced Apoptosis in Pancreatic β-Cells
Jun Shirakawa et al.
DIABETES (2013)
Dose-ranging study with the glucokinase activator AZD1656 as monotherapy in Japanese patients with type 2 diabetes mellitus
A. Kiyosue et al.
DIABETES OBESITY & METABOLISM (2013)
Imatinib mesilate-induced phosphatidylinositol 3-kinase signalling and improved survival in insulin-producing cells: role of Src homology 2-containing inositol 5′-phosphatase interaction with c-Abl
D. Mokhtari et al.
DIABETOLOGIA (2013)
Glucocorticoid-Induced Suppression of β-Cell Proliferation Is Mediated by Mig6
E. Scott Colvin et al.
ENDOCRINOLOGY (2013)
Tyrosine kinase inhibitors as novel drugs for the treatment of diabetes
Patricia O. Prada et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2013)
β-cell adaptation in a mouse model of glucocorticoid-induced metabolic syndrome
Liselotte Fransson et al.
JOURNAL OF ENDOCRINOLOGY (2013)
Combined inhibition of Chk1 and Wee1 In vitro synergistic effect translates to tumor growth inhibition in vivo
Laura Carrassa et al.
CELL CYCLE (2012)
Glucose metabolism: key endogenous regulator of β-cell replication and survival
D. Dadon et al.
DIABETES OBESITY & METABOLISM (2012)
Effects of glucocorticoids and exercise on pancreatic β-cell function and diabetes development
Jacqueline L. Beaudry et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2012)
Control of beta cell function and proliferation in mice stimulated by small-molecule glucokinase activator under various conditions
A. Nakamura et al.
DIABETOLOGIA (2012)
Pancreatic Beta Cells in Very Old Mice Retain Capacity for Compensatory Proliferation
Miri Stolovich-Rain et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Overexpression of Hepatocyte Nuclear Factor-4α Initiates Cell Cycle Entry, but Is not Sufficient to Promote β-Cell Expansion in Human Islets
Sebastian Rieck et al.
MOLECULAR ENDOCRINOLOGY (2012)
Adenosine kinase inhibition selectively promotes rodent and porcine islet β-cell replication
Justin P. Annes et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Forced Mitotic Entry of S-Phase Cells as a Therapeutic Strategy Induced by Inhibition of WEE1
Marieke Aarts et al.
CANCER DISCOVERY (2012)
WEE1 Kinase Targeting Combined with DNA-Damaging Cancer Therapy Catalyzes Mitotic Catastrophe
Philip C. De Witt Hamer et al.
CLINICAL CANCER RESEARCH (2011)
Genetic evidence of the programming of beta cell mass and function by glucocorticoids in mice
B. Valtat et al.
DIABETOLOGIA (2011)
The adaptive compensations in endocrine pancreas from glucocorticoid-treated rats are reversible after the interruption of treatment
A. Rafacho et al.
ACTA PHYSIOLOGICA (2010)
Effect of the tyrosine kinase inhibitors (sunitinib, sorafenib, dasatinib, and imatinib) on blood glucose levels in diabetic and nondiabetic patients in general clinical practice
Nicole M Agostino et al.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE (2010)
High doses of dexamethasone induce increased β-cell proliferation in pancreatic rat islets
Alex Rafacho et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2009)
Imatinib Mesylate Reduces Endoplasmic Reticulum Stress and Induces Remission of Diabetes in db/db Mice
Myoung Sook Han et al.
DIABETES (2009)
Impact of Small-Molecule Glucokinase Activator on Glucose Metabolism and β-Cell Mass
Akinobu Nakamura et al.
ENDOCRINOLOGY (2009)
Regulation of beta cell replication
Ying C. Lee et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2009)
Tyrosine kinase inhibitors reverse type 1 diabetes in nonobese diabetic mice
Cedric Louvet et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Amelioration of diabetes by imatinib mesylate (Gleevec®):: role of β-cell NF-κB activation and anti-apoptotic preconditioning
Robert Hagerkvist et al.
FASEB JOURNAL (2007)
Glucocorticoid signalling affects pancreatic development through both direct and indirect effects
E. Gesina et al.
DIABETOLOGIA (2006)
Dexamethasone induces cell death in insulin-secreting cells, an effect reversed by exendin-4
F Ranta et al.
DIABETES (2006)
Statistical practice in high-throughput screening data analysis
N Malo et al.
NATURE BIOTECHNOLOGY (2006)
Cell cycle regulation in the G1 phase: A promising target for the development of new chemotherapeutic anticancer agents
T Owa et al.
CURRENT MEDICINAL CHEMISTRY (2001)
Share Paper
